Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 2Short Bowel Syndrome 1Esophageal Squamous Cell Carcinoma 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Octreotide 3maltodextrin 1lanreotide 1Sulfasalazine 1Radiation 1Probiotics 1Loperamide 1Levofloxacin 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Diarrhea × Loperamide × Clear all
NCT00003057 2023-06-18

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
500 enrolled
Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡